Formening Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Side Effects Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Meningococcal (groups A, C, Y & W-135) polysaccharide vaccine

Indications/Uses

Prevention of meningococcal disease caused by epidemic Neisseria meningitidis serogroups A, C, Y & W-135.

Click to view Formening detailed prescribing information

Dosage/Direction for Use

0.5 mL as single SC dose in the outer aspect of the deltoid.

Click to view Formening detailed prescribing information

Contraindications

Not to be administered in patients w/ history of epilepsy, convulsions, brain disorder or allergies; kidney or heart disease, active TB, acute infections & fever. Not recommended in pregnant women, especially in the 1st 3 mth.

Click to view Formening detailed prescribing information

Special Precautions

Do not administer intradermally, IM & IV. Observe patient for at least 30 min after vaccination for possible anaphylactic reactions; appropriate medical treatment eg, epinephrine or other drugs must be available. May not be associated w/ pertussis vaccine & typhoid bacteria cell vaccine inj at the same time. Immunosuppressed patients, including those receiving immunosuppressive therapy, may have a diminished immune response to vaccine. Not indicated for treatment of meningococcal infections, not able to protect from group B meningococcal. Lactation. Do not provide short-term prevention for infants & childn <2 yr but provide short-term protection for childn ≥3 mth from group A meningococcal.

Click to view Formening detailed prescribing information

Adverse Reactions

Slight pain at inj site; local, mild swelling, redness & itching. Mild fever (<37.5°C); fatigue, drowsiness, myalgia, abdominal pain, loss of appetite, irritability, diarrhea, vomiting, rash.

Storage

View Formening storage conditions for details to ensure optimal shelf-life.

Description

View Formening description for details of the chemical structure and excipients (inactive components).

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07AH04 - meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen ; Belongs to the class of meningococcal bacterial vaccines.

Regulatory Classification

Presentation/Packing

Form

Formening powd for inj 200 mcg

Packing/Price

((vial) + 0.5 mL diluent (amp)) 1's

Formening

vaccine, meningococcal

Manufacturer:

Mersifarma TM